Here are five highlights:
1. The congress offered information about the latest techniques and data related to endoscopic spine surgery.
2. Joimax develops technologies and training methods for endoscopic minimally invasive spine surgery.
3. The device company highlighted its MultiZYTE RT, MultiZYTE SI for Sacroiliac Joint therapy and the Intracs Intraoperative Navigation Tracking & Control System.
4. During the congress, joimax hosted two lunch symposiums focused on surgical indications and pain therapy.
5. Alastair Gibson, MD, of Edinburgh, Scotland, recently published a study that highlights the benefits of endoscopic MIS, “A randomized controlled trial of TED vs Microdiscectomy,” in the European Spine Journal.
“Endoscopic minimally invasive techniques are becoming more and more the first choice in spinal surgery. This is also reflected in the steadily and now fast growing number of studies showing the benefits on these treatment modalities,” said Wolfgang Ries, CEO and founder, joimax.
More articles on MIS:
Dr. Richard Kube reports 12-month results of SImmetry Sacroiliac Joint Fusion study — 3 takeaways
5 key notes on Medicare patients undergoing minimally invasive spine surgery — complications, operative time and more
MIS serves as driver of global surgical microscope market: 8 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
